Accrued Liabilities - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Accrued Liabilities Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Accrued Liabilities
€1.8m
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Accrued Liabilities
€41.5m
CAGR 3-Years
50%
CAGR 5-Years
36%
CAGR 10-Years
26%
Nanobiotix SA
PAR:NANO
Accrued Liabilities
€7.4m
CAGR 3-Years
4%
CAGR 5-Years
110%
CAGR 10-Years
23%
Innate Pharma SA
PAR:IPH
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genfit SA
NASDAQ:GNFT
Accrued Liabilities
€4.2m
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Accrued Liabilities
€6.1m
CAGR 3-Years
5%
CAGR 5-Years
20%
CAGR 10-Years
6%

See Also

What is Gensight Biologics SA's Accrued Liabilities?
Accrued Liabilities
1.8m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Accrued Liabilities amounts to 1.8m EUR.

What is Gensight Biologics SA's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
-1%

Over the last year, the Accrued Liabilities growth was -50%. The average annual Accrued Liabilities growth rates for Gensight Biologics SA have been -12% over the past three years , -1% over the past five years .

Back to Top